Tarsus Pharmaceuticals (NASDAQ:TARS) Publishes Corporate Presentation – Enhances Stakeholder InsightOn January 13, 2025, Tarsus Pharmaceuticals, Inc. shared its corporate presentation on its website’s Investor & News section, as detailed in the lates

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Tarsus Pharmaceuticals’s 8K filing here. About Tarsus Pharmaceuticals (Get Free Report) Tarsus Pharmaceuticals, Inc, a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care […]

Leave a Reply

Your email address will not be published.

Previous post KULR Technology Group Ratifies Issuance of Non-Convertible Series A Voting Preferred Stock to CEO
Next post Tredegar Corporation Appoints Christine R. Vlahcevic to Board of DirectorsOn January 9, 2025, Tredegar Corporation (NYSE: TG) announced a significant development in its leadership structure by appointing Christine R. Vlahcevic as a director of the Co